Product Information
SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.1153 per ML under NDC 50742038642. Its NADAC has been published 77 times since Feb 12, 2025.
FDA first approved this application on Mar 21, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/10mL
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742038642
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA216726FDA Approved
3/21/2024
TE Code
AB
On Market Since
11/21/2024
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 77 times since Feb 12, 2025, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1153 per ML |
|---|---|
| All-time high | $0.2304 (Feb 12, 2025) |
| All-time low | $0.1153 (Jul 22, 2026) |
| 52-week high | $0.1253 |
| 52-week low | $0.1153 |
| Median price | $0.1239 |
| Average price | $0.1348 |
| Largest weekly change | -14.7% (Feb 19, 2025) |
| Weeks tracked | 77 |
| Tracking since | Feb 12, 2025 |
1W
N/A
1M
N/A
3M
-1.8%
6M
-3.5%
1Y
-6.0%
3Y
N/A
5Y
N/A
All
-50.0%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sucralfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aluminum Complex class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by Ingenus Pharmaceuticals LLC, is $0.1153 per ML (NDC 50742038642), effective Jul 29, 2026.
How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 50.0%. It has been tracked across 77 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?
Since Feb 12, 2025, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.1153 (Jul 22, 2026) to a high of $0.2304 (Feb 12, 2025), with a median of $0.1239 per ML.
Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUCRALFATE 1 GM/10 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures SUCRALFATE 1 GM/10 ML SUSP?
SUCRALFATE 1 GM/10 ML SUSP (NDC 50742038642) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.